1. Home
  2. MIST vs SAMG Comparison

MIST vs SAMG Comparison

Compare MIST & SAMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • SAMG
  • Stock Information
  • Founded
  • MIST 2003
  • SAMG 2002
  • Country
  • MIST Canada
  • SAMG United States
  • Employees
  • MIST N/A
  • SAMG N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • SAMG Investment Managers
  • Sector
  • MIST Health Care
  • SAMG Finance
  • Exchange
  • MIST Nasdaq
  • SAMG Nasdaq
  • Market Cap
  • MIST 132.5M
  • SAMG 151.1M
  • IPO Year
  • MIST N/A
  • SAMG 2013
  • Fundamental
  • Price
  • MIST $1.70
  • SAMG $16.78
  • Analyst Decision
  • MIST Strong Buy
  • SAMG
  • Analyst Count
  • MIST 2
  • SAMG 0
  • Target Price
  • MIST $7.50
  • SAMG N/A
  • AVG Volume (30 Days)
  • MIST 938.8K
  • SAMG 24.8K
  • Earning Date
  • MIST 08-12-2025
  • SAMG 07-31-2025
  • Dividend Yield
  • MIST N/A
  • SAMG 5.24%
  • EPS Growth
  • MIST N/A
  • SAMG N/A
  • EPS
  • MIST N/A
  • SAMG 0.87
  • Revenue
  • MIST N/A
  • SAMG $124,451,000.00
  • Revenue This Year
  • MIST N/A
  • SAMG $3.93
  • Revenue Next Year
  • MIST N/A
  • SAMG $5.56
  • P/E Ratio
  • MIST N/A
  • SAMG $19.30
  • Revenue Growth
  • MIST N/A
  • SAMG 4.13
  • 52 Week Low
  • MIST $0.63
  • SAMG $13.54
  • 52 Week High
  • MIST $2.75
  • SAMG $19.20
  • Technical
  • Relative Strength Index (RSI)
  • MIST 54.42
  • SAMG 57.70
  • Support Level
  • MIST $1.62
  • SAMG $15.99
  • Resistance Level
  • MIST $1.75
  • SAMG $16.40
  • Average True Range (ATR)
  • MIST 0.08
  • SAMG 0.37
  • MACD
  • MIST 0.02
  • SAMG -0.02
  • Stochastic Oscillator
  • MIST 82.76
  • SAMG 79.00

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

Share on Social Networks: